answer text |
<p> </p><p>The focus of Girl Summit 2014 was on ending female genital mutilation and
child, early and forced marriage. No specific assessment was made at the Summit on
the role of the GAVI Alliance in safeguarding the health of women and girls or addressing
gender-related barriers to accessing immunisation services. However, GAVI is rolling-out
two vaccines that will directly benefit girls and women: rubella vaccine, which protects
against a disease damaging to unborn children; and Human Papilloma Virus (HPV) vaccine,
which helps prevent cervical cancer, one of the leading causes of death in young women
in sub-Saharan Africa. GAVI will immunise over 30 million girls with HPV vaccines
during 2013-2020 which will prevent over 150,000 women dying each year. GAVI is working
to overcome the barriers to introducing the HPV vaccine in developing countries by
reducing the high cost of the vaccine and tackling the challenges of immunising girls
aged nine to thirteen years by integrating HPV immunisation with wider health interventions
targeted at adolescent girls.</p><p> </p><p> </p><p> </p><p>The UK’s support to GAVI
remains a highly cost effective way to achieve childhood immunisation results at scale.
The 2011 UK Multilateral Aid Review (MAR) ranked GAVI as being very good value for
money. The 2013 MAR Update confirmed that GAVI is continuing to make reasonable progress.
An example of this is that GAVI helped to secure a reduction in price of 35% between
2010-2012 of the three vaccines it spends the most money on.</p><p> </p>
|
|